Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer
NSCLC
1 other identifier
observational
50
1 country
1
Brief Summary
The purpose of this study is to investigate the changes of lymphocyte subsets in chemotherapy course of patients with non-small cell lung cancer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 24, 2014
CompletedFirst Posted
Study publicly available on registry
July 29, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedJuly 29, 2014
July 1, 2014
1.1 years
June 24, 2014
July 28, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the changes of patients' lymphocyte subsets in chemotherapy courses.
up to cycle 4 day 9
Eligibility Criteria
patients with non-small cell lung cancer who accept chemotherapy for the first time are acceptable.
You may qualify if:
- Each Period Non-small Cell Lung Cancer, Which Was Confirmed by Histopathology. patients has only lung cancer .
- Functional Status Score (PS) ≧ 70.
- The first time for chemotherapy .
- A Written Informed Consent.
You may not qualify if:
- Merging other tumors.
- HAve autoimmune diseases.
- AIDS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
WangQian
Beijing, Beijing Municipality, 100020, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
yingmin ma
Vice President of the Beijing chaoyang hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice President of the Beijing chaoyang hospital
Study Record Dates
First Submitted
June 24, 2014
First Posted
July 29, 2014
Study Start
May 1, 2014
Primary Completion
June 1, 2015
Study Completion
September 1, 2015
Last Updated
July 29, 2014
Record last verified: 2014-07